A retrospective cohort pilot study to evaluate a triage tool for use in a pandemic

Table 5 Analysis of patients who were ever triaged blue or met exclusion criteria

	Survived			Expired
	Exclusion criteria/MQS	triaged blue	Total	Exclusion criteria/MQS	triaged blue	Total
N	13	17	30	43	20	63
90-day status*				N/A	N/A	N/A
N (%)	0	1 (5.9)	1 (3.3)	N/A	N/A	N/A
Life support (%)				N/A	N/A	N/A
Medical care (%)		1	1	N/A	N/A	N/A
Awaiting cc/rehab				N/A	N/A	N/A
Discharged				N/A	N/A	N/A
N (%)				N/A	N/A	N/A
Home	6 (46.1)	7 (23.3)	13 (43.3)	N/A	N/A	N/A
Chronic care	4 (30.8)	0	4 (13.3)	N/A	N/A	N/A
Acute care	3 (23.1)	5 (29.4)	8 (26.7)	N/A	N/A	N/A
Rehab	0	5 (29.4)	5 (16.7)	N/A	N/A	N/A
Time of endpoint
Admission	13 (100)	3 (17.7)	16 (53.3)	40 (93.0)	9 (45.0)	49 (77.8)
48 hours		10 (58.8)	10 (33.3)	1 (2.3)	11 (55.0)	12 (19.1)
120 hours		4 (23.5)	4 (13.3)	0	0	0
other		N/A	0	2 (4.7)	0	2 (3.2)
Blue triage SOFA criteria
Admission > 11	N/A	3		N/A	9
48 hour > 11	N/A	1		N/A	6
48 hour 8-11 & no change	N/A	9		N/A	4
120 hour > 11	N/A	0		N/A	1
120 hour < 8 & no change	N/A	4		N/A	0
Exclusion criteria
Severe trauma	0	N/A		4	N/A
Severe burn	0	N/A		0	N/A
Cardiac arrest	1	N/A		12	N/A
Severe cognitive impairment	0	N/A		0	N/A
Advanced neuromuscular disease	0	N/A		0	N/A
Metastatic malignancy	5	N/A		6	N/A
Advanced & irreversible immunocompromise	0	N/A		0	N/A
Severe & irreversible neurologic event/condition	1	N/A		12	N/A
End-stage heart failure	1	N/A		1	N/A
End-stage lung failure	0	N/A		3	N/A
End-stage liver failure	1	N/A		0	N/A
Age > 85	3	N/A		10	N/A
> 6 u PRBC within 24 hours	1	N/A		1	N/A
Elective palliative surgery	1	N/A		0	N/A
SOFA > 11 non-triage days	0	N/A		2	N/A

* if still admitted to hospital
cc = chronic care; MQS = minimum qualifications for survival; N/A = not available; PRBC = packed red blood cells; rehab = rehabilitation; SOFA = sequential organ failure assessment.

ISSN: 1364-8535